Vancomycin: a review of population pharmacokinetic analyses

Clinical Pharmacokinetics
Amélie MarsotN Simon


Despite nearly five decades of clinical use, vancomycin has retained a significant and uncontested niche in the antibacterial arsenal because of its consistent activity against almost all Gram-positive bacteria. Nevertheless, major vancomycin toxicities have been reported in the literature - in particular, nephrotoxicity and ototoxicity. Vancomycin pharmacokinetics have been described in numerous studies for 25 years. This review presents a synthesis of the reported population pharmacokinetic models of vancomycin. The objective was to determine if there was a consensus on a structural model and which covariates were identified. A literature search was conducted from the PubMed database, from its inception through December 2010, using the following terms: 'vancomycin', 'pharmacokinetic(s)', 'population', 'model(ling)' and 'nonlinear mixed effect'. Articles were excluded if they were not pertinent. The reference lists of all selected articles were also evaluated. Twenty-five articles were included in this review: 15 models concerned paediatric patients and ten models were conducted in adults. In neonates and infants, the pharmacokinetics of vancomycin were mainly described by a one-compartment model, whereas in adults, a two-comp...Continue Reading


Oct 1, 1990·Clinical Pharmacokinetics·C M Paap, M C Nahata
May 1, 1988·Clinical Pharmacology and Therapeutics·T A GolperW M Bennett
Jul 1, 1986·Clinical Pharmacokinetics·G R MatzkeD R Guay
May 1, 1986·Pediatric Infectious Disease·D H SchaibleS A Plotkin
Jan 1, 1985·Pediatric Pharmacology·J R GrossE O Mason
Dec 1, 1984·Clinical Pharmacology and Therapeutics·N R CutlerM Power
Oct 1, 1994·Therapeutic Drug Monitoring·M P DucharmeD J Edwards
Aug 1, 1994·Clinical Pharmacology and Therapeutics·R E SeayB E Edgren
Apr 1, 1993·The Annals of Pharmacotherapy·W H AsburyC C Capers
Apr 29, 1998·Therapeutic Drug Monitoring·M YasuharaR Hori
Dec 16, 1998·Therapeutic Drug Monitoring·M YasuharaR Hori
Jan 7, 1999·The Journal of Pharmacy and Pharmacology·R SilvaA C Falcão
Apr 2, 1999·Pediatrics·J P Guignard, A Drukker
Aug 18, 1999·Archives of Disease in Childhood·R KumarN Kohli
Oct 19, 1999·Archives of Disease in Childhood. Fetal and Neonatal Edition·C Grimsley, A H Thomson
May 9, 2000·Clinical Pharmacology and Therapeutics·M de HoogJ N van den Anker
Oct 18, 2000·Therapeutic Drug Monitoring·R E WrishkoD Hamilton
Sep 11, 2001·Journal of Clinical Pharmacology·E V CapparelliJ D Connor
Jan 5, 2002·Journal of Chemotherapy·V Fanos, L Cataldi
Mar 30, 2004·Antimicrobial Agents and Chemotherapy·Toshimi KimuraKazuo Yago
Feb 11, 2005·Seminars in Fetal & Neonatal Medicine·Matthijs de HoogJohn N van den Anker
Aug 27, 2005·British Journal of Clinical Pharmacology·Hussain Mulla, Suneel Pooboni
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Dolores Santos BuelgaMaría José García
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Donald P Levine
Jul 28, 2006·British Journal of Clinical Pharmacology·Brian J AndersonNicholas H G Holford
Sep 9, 2006·Journal of Clinical Pharmacy and Therapeutics·P Llopis-Salvia, N V Jiménez-Torres
Oct 5, 2007·Annual Review of Pharmacology and Toxicology·B J Anderson, N H G Holford
Oct 31, 2009·Burns : Journal of the International Society for Burn Injuries·Michael DoltonAndrew J McLachlan
Nov 26, 2009·Antimicrobial Agents and Chemotherapy·Akihiro TanakaHiroaki Araki
Feb 24, 2010·Antimicrobial Agents and Chemotherapy·Pia Schulz zur WieschSebastian Bonhoeffer
Jul 24, 2010·International Journal of Clinical Pharmacology and Therapeutics·J L SánchezJ M Cornejo-Bravo
Jul 27, 2010·British Journal of Clinical Pharmacology·Natalia RevillaMaría Del Mar Fernández de Gatta
Nov 3, 2010·British Journal of Clinical Pharmacology·María-Remedios Marqués-MiñanaJosé-Esteban Peris
Feb 5, 2011·Archives of Disease in Childhood. Fetal and Neonatal Edition·Martin Ward Platt
Mar 8, 2011·Archives of Disease in Childhood. Fetal and Neonatal Edition·C OudinN Simon

❮ Previous
Next ❯


Dec 21, 2012·Archives of Disease in Childhood·Wei ZhaoEvelyne Jacqz-Aigrain
Jan 24, 2013·The Pediatric Infectious Disease Journal·Jennifer LeEdmund V Capparelli
Feb 26, 2013·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Katherine L Boyle, Christopher D Rosenbaum
Aug 21, 2015·Expert Review of Clinical Pharmacology·Evelyne Jacqz-AigrainMike Sharland
Nov 17, 2015·The Journal of Antimicrobial Chemotherapy·Susanna E Medellín-GaribayEmilia Barcia
Mar 22, 2016·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Emily C BenefieldPeter N Johnson
Sep 29, 2015·Journal of Clinical Pharmacology·Jiraganya Jj BhongsatiernCatherine M T Sherwin
Oct 11, 2014·Expert Review of Anti-infective Therapy·Chris StockmannCatherine M T Sherwin
Oct 31, 2017·Therapeutic Drug Monitoring·Tõnis TasaIrja Lutsar
Mar 2, 2018·Therapeutic Drug Monitoring·Paul Lewis
Mar 22, 2018·Therapeutic Drug Monitoring·Timothy M RawsonAlison H Holmes
Dec 6, 2014·Hospital Pharmacy·Dennis J CadaDanial E Baker
Dec 22, 2017·Antimicrobial Agents and Chemotherapy·Muhammed Taufiq Bin JumahChristine B Teng
Feb 21, 2018·The Pediatric Infectious Disease Journal·Abdullah AlsultanFahad Alzamil
Mar 11, 2015·Antimicrobial Agents and Chemotherapy·Anaïs GlatardSylvain Goutelle
Mar 13, 2014·Antimicrobial Agents and Chemotherapy·Julianne KimAndrew Simor
Mar 26, 2014·Antimicrobial Agents and Chemotherapy·Wei ZhaoEvelyne Jacqz-Aigrain
Oct 30, 2013·Antimicrobial Agents and Chemotherapy·Michael N NeelyThomas P Lodise
May 18, 2016·Antimicrobial Agents and Chemotherapy·Laurent BourguignonSylvain Goutelle
Jan 18, 2017·Antimicrobial Agents and Chemotherapy·Manjunath P PaiLynne Krop
Mar 6, 2019·Antimicrobial Agents and Chemotherapy·Frank KloproggeJoseph F Standing
Mar 21, 2019·Current Pharmaceutical Biotechnology·Nadielle S BiduRicardo D Couto
Jul 16, 2013·Therapeutic Drug Monitoring·Daniel L BrownAndrew J Masselink
Jun 4, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Keith A Rodvold
Jun 4, 2019·European Journal of Drug Metabolism and Pharmacokinetics·Hirokazu NakayamaHirotoshi Echizen
Oct 30, 2019·British Journal of Clinical Pharmacology·Cornelis SmitCatherijne A J Knibbe
Feb 18, 2020·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Edwin LamJingjing Zhang
Apr 17, 2020·European Journal of Hospital Pharmacy. Science and Practice·Sook Hee AnHye Sun Gwak

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.